Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.

Samuel ShribmanCarolin HellerMaggie BurrowsAmanda HeslegraveImogen SwiftMartha S FoianiGodfrey T GillettEmmanuel A TsochatzisJames Benedict RoweAlex GerhardChris R ButlerMario MasellisFion BremnerAlison MartinLynne JungPaul CookHenrik ZetterbergOliver BandmannJonathan D RohrerThomas T Warner

Published in: Movement disorders : official journal of the Movement Disorder Society (2020)

NfL is a biomarker of neurological involvement with potential use in guiding chelation therapy and clinical trials for novel treatments. © 2020 University College London. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

clinical trial
cerebrospinal fluid
cerebral ischemia
phase ii
risk assessment
brain injury
bone marrow
open label
study protocol
cell therapy
subarachnoid hemorrhage